Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.62 |
| ▸ | CNR2 | P34972 | 4/20 | 0.62 |
| ▸ | FASN | P49327 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1918392 | 1.00 | CNR1 (0.62) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL17555971 | 1.00 | CNR1 (0.62) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL16658754 | 0.98 | CNR1 (0.65) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL16658750 | 0.98 | CNR1 (0.65) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL16658751 | 0.98 | CNR1 (0.65) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL16658753 | 0.98 | CNR1 (0.65) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL16658752 | 0.98 | CNR1 (0.65) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL16658749 | 0.98 | CNR1 (0.65) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL10451633 | 0.85 | CNR1 (0.62) | CNR1CNR2FASNKDM4EALDH1A1 | |
| SCHEMBL16658737 | 0.85 | PSMB11 (0.54) | CNR1CNR2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2158894-B1 | Oral cleansing agent | HENKEL AG & CO KGAA (DE) | 2018-11-07 | — | — | EP | disclosed |
| EP-2140853-B1 | Coated particle for use in cosmetics | HENKEL AG & CO KGAA (DE) | 2018-07-18 | — | — | EP | disclosed |
| EP-2347754-B1 | Oral and tooth care and cleaning agents with alkylpyridinium salts I | HENKEL AG & CO KGAA (DE) | 2018-01-24 | — | — | EP | disclosed |
| EP-2347753-B1 | Oral and tooth care and cleaning agents with alkylpyridine salts II | HENKEL AG & CO KGAA (DE) | 2016-12-28 | — | — | EP | disclosed |
| EP-3003500-A1 | ORAL AND DENTAL HYGIENE- AND CLEANING AGENTS FOR SENSITIVE TEETH | Henkel AG & Co. KGaA (DE) | 2016-04-13 | — | — | EP | disclosed |
| EP-3003498-A1 | TOOTHPASTE CONTAINING FLUORIDE AND POLYLACTIC ACID PARTICLES | Henkel AG & Co. KGaA (DE) | 2016-04-13 | — | — | EP | disclosed |
| US-20160067169-A1 | TOOTHPASTE CONTAINING FLUORIDE AND POLYLACTIC ACID PARTICLES | HENKEL AG & CO. KGAA (DE) | 2016-03-10 | — | — | US | disclosed |
| US-20160067171-A1 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS WITH OPTIMIZED TASTE | HENKEL AG & CO. KGAA (DE) | 2016-03-10 | — | — | US | disclosed |
| US-20160067168-A1 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS FOR SENSITIVE TEETH | HENKEL AG & CO. KGAA (DE) | 2016-03-10 | — | — | US | disclosed |
| US-20160067170-A1 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS WITH IMPROVED ANTI-BACTERIAL ACTION | HENKEL AG & CO. KGAA (DE) | 2016-03-10 | — | — | US | disclosed |
| WO-2008049651-A1 | PERFORMANCE-ENHANCED COSMETIC COMPOSITIONS WITH PURINE AND/OR PURINE DERIVATIVES | HENKEL AG & CO. KGAA (DE) | 2008-05-02 | — | — | WO | disclosed |
| EP-1880705-A2 | Brightening and/or colouring composition with improved product sensation | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-01-23 | — | — | EP | disclosed |
| WO-2007147815-A1 | DENTAL TREATMENT COMPOSITION WITH INCREASED BLEACHING EFFECT | HENKEL AG & CO. KGAA (DE) | 2007-12-27 | — | — | WO | disclosed |
| EP-1842573-A2 | Brightening and/or colouring agent with improved product sensation | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-10-10 | — | — | EP | disclosed |
| EP-1806124-A1 | Dental preparations comprising enzymes | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-07-11 | — | — | EP | disclosed |
| EP-1806126-A1 | Dental preparations comprising enzymes | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-07-11 | — | — | EP | disclosed |
| EP-1774953-A2 | Mouthwash concentrate | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-04-18 | — | — | EP | disclosed |
| EP-1774955-A2 | Ready-to-use mounthwash | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-04-18 | — | — | EP | disclosed |
| EP-1774956-A2 | Mouthwash and dentifrice and cleansing composition | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-04-18 | — | — | EP | disclosed |
| EP-1774954-A2 | Mouthwash and dentifrice and cleansing composition | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067170-A1 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS WITH IMPROVED ANTI-BACTERIAL ACTION | USP39, USP30, SOD1 | CNR1 4665/4885CNR2 4640/4885FASN 2194/4885 |
| US-20160067168-A1 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS FOR SENSITIVE TEETH | SI, H1-0, POLD1 | CNR1 4192/4885CNR2 4395/4885FASN 3754/4885 |
| US-20160067171-A1 | ORAL AND DENTAL HYGIENE AND CLEANING AGENTS WITH OPTIMIZED TASTE | SORD, TAS2R40, TREH | CNR1 3786/4885CNR2 3212/4885FASN 3284/4885 |
| US-20160067169-A1 | TOOTHPASTE CONTAINING FLUORIDE AND POLYLACTIC ACID PARTICLES | PUF60, POLI, FIP1L1 | CNR1 4440/4885CNR2 4461/4885FASN 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.